Literature DB >> 22475744

The Varicella-zoster virus ORF54 gene product encodes the capsid portal protein, pORF54.

Alexander J Howard1, Debra M Sherman, Melissa A Visalli, Denise M Burnside, Robert J Visalli.   

Abstract

The Varicella-zoster virus (VZV) ORF54 gene was characterized using a guinea pig antiserum prepared to a GST-pORF54 fusion protein. A protein of the predicted size, 87kDa, was detected in VZV-infected MeWo cells but not in mock-infected cells. Sucrose density gradient fractionation of pORF54 expressed in a recombinant baculovirus system resulted in samples containing enriched amounts of pORF54. Electron microscopic analysis suggested that the ORF54 gene encodes a protein that assembles into ring-like portal structures similar to those observed for numerous bacteriophages and other herpesviruses.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22475744      PMCID: PMC3361546          DOI: 10.1016/j.virusres.2012.03.013

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  17 in total

1.  Identification of small molecule compounds that selectively inhibit varicella-zoster virus replication.

Authors:  Robert J Visalli; Jeanette Fairhurst; Shamala Srinivas; William Hu; Boris Feld; Martin DiGrandi; Kevin Curran; Adma Ross; Jonathan D Bloom; Marja van Zeijl; Thomas R Jones; John O'Connell; Jeffrey I Cohen
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

Review 2.  DNA encapsidation as a target for anti-herpesvirus drug therapy.

Authors:  Robert J Visalli; Marja van Zeijl
Journal:  Antiviral Res       Date:  2003-07       Impact factor: 5.970

3.  Inhibition of herpes simplex virus replication by WAY-150138: assembly of capsids depleted of the portal and terminase proteins involved in DNA encapsidation.

Authors:  William W Newcomb; Jay C Brown
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

4.  Thiourea inhibitors of herpesviruses. Part 3: Inhibitors of varicella zoster virus.

Authors:  Martin J Di Grandi; Kevin J Curran; Gregg Feigelson; Amar Prashad; Adma A Ross; Robert Visalli; Jeanette Fairhurst; Boris Feld; Jonathan D Bloom
Journal:  Bioorg Med Chem Lett       Date:  2004-08-16       Impact factor: 2.823

5.  Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action.

Authors:  J Reefschlaeger; W Bender; S Hallenberger; O Weber; P Eckenberg; S Goldmann; M Haerter; I Buerger; J Trappe; J A Herrington; D Haebich; H Ruebsamen-Waigmann
Journal:  J Antimicrob Chemother       Date:  2001-12       Impact factor: 5.790

6.  Novel class of thiourea compounds that inhibit herpes simplex virus type 1 DNA cleavage and encapsidation: resistance maps to the UL6 gene.

Authors:  M van Zeijl; J Fairhurst; T R Jones; S K Vernon; J Morin; J LaRocque; B Feld; B O'Hara; J D Bloom; S V Johann
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

7.  A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products.

Authors:  I Buerger; J Reefschlaeger; W Bender; P Eckenberg; A Popp; O Weber; S Graeper; H D Klenk; H Ruebsamen-Waigmann; S Hallenberger
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 8.  Human cytomegalovirus terminase as a target for antiviral chemotherapy.

Authors:  Elke Bogner
Journal:  Rev Med Virol       Date:  2002 Mar-Apr       Impact factor: 6.989

9.  Crystal structure of the DNA-recognition component of the bacterial virus Sf6 genome-packaging machine.

Authors:  Haiyan Zhao; Casey J Finch; Reuben D Sequeira; Brian A Johnson; John E Johnson; Sherwood R Casjens; Liang Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-19       Impact factor: 11.205

10.  The UL6 gene product forms the portal for entry of DNA into the herpes simplex virus capsid.

Authors:  W W Newcomb; R M Juhas; D R Thomsen; F L Homa; A D Burch; S K Weller; J C Brown
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more
  5 in total

1.  The varicella-zoster virus portal protein is essential for cleavage and packaging of viral DNA.

Authors:  Melissa A Visalli; Brittany L House; Anca Selariu; Hua Zhu; Robert J Visalli
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

2.  Non-axial view of the varicella-zoster virus portal protein reveals conserved crown, wing and clip architecture.

Authors:  Robert J Visalli; Alexander J Howard
Journal:  Intervirology       Date:  2014-03-14       Impact factor: 1.763

Review 3.  Tegument Assembly and Secondary Envelopment of Alphaherpesviruses.

Authors:  Danielle J Owen; Colin M Crump; Stephen C Graham
Journal:  Viruses       Date:  2015-09-18       Impact factor: 5.048

4.  Atomic structure of the Epstein-Barr virus portal.

Authors:  Cristina Machón; Montserrat Fàbrega-Ferrer; Daming Zhou; Ana Cuervo; José L Carrascosa; David I Stuart; Miquel Coll
Journal:  Nat Commun       Date:  2019-08-29       Impact factor: 14.919

Review 5.  Breaking Symmetry in Viral Icosahedral Capsids as Seen through the Lenses of X-ray Crystallography and Cryo-Electron Microscopy.

Authors:  Kristin N Parent; Jason R Schrad; Gino Cingolani
Journal:  Viruses       Date:  2018-02-07       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.